126 related articles for article (PubMed ID: 18303228)
1. A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients.
Alagoz G; Gürel K; Bayer A; Serin D; Celebi S; Kukner S
Ophthalmologica; 2008; 222(2):88-95. PubMed ID: 18303228
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
[TBL] [Abstract][Full Text] [Related]
3. Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Cantor LB; Hoop J; Morgan L; Wudunn D; Catoira Y;
Br J Ophthalmol; 2006 Nov; 90(11):1370-3. PubMed ID: 16825272
[TBL] [Abstract][Full Text] [Related]
4. Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension.
Akarsu C; Yilmaz S; Taner P; Ergin A
Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):814-8. PubMed ID: 15069567
[TBL] [Abstract][Full Text] [Related]
5. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428].
Zeitz O; Matthiessen ET; Reuss J; Wiermann A; Wagenfeld L; Galambos P; Richard G; Klemm M
BMC Ophthalmol; 2005 Apr; 5():6. PubMed ID: 15811188
[TBL] [Abstract][Full Text] [Related]
6. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
[TBL] [Abstract][Full Text] [Related]
7. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol.
Inan UU; Ermis SS; Orman A; Onrat E; Yucel A; Ozturk F; Asagidag A; Celik A
J Ocul Pharmacol Ther; 2004 Aug; 20(4):293-310. PubMed ID: 15321024
[TBL] [Abstract][Full Text] [Related]
8. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
9. Effects of bimatoprost 0.03% on ocular hemodynamics in normal tension glaucoma.
Chen MJ; Cheng CY; Chen YC; Chou CK; Hsu WM
J Ocul Pharmacol Ther; 2006 Jun; 22(3):188-93. PubMed ID: 16808680
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
[TBL] [Abstract][Full Text] [Related]
11. Bimatoprost versus travoprost in an Egyptian population: a hospital-based prospective, randomized study.
Macky TA
J Ocul Pharmacol Ther; 2010 Dec; 26(6):605-10. PubMed ID: 21034177
[TBL] [Abstract][Full Text] [Related]
12. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
13. Comparing bimatoprost and travoprost in black Americans.
Noecker RJ; Earl ML; Mundorf TK; Silverstein SM; Phillips MP
Curr Med Res Opin; 2006 Nov; 22(11):2175-80. PubMed ID: 17076978
[TBL] [Abstract][Full Text] [Related]
14. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Nixon DR
J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
[TBL] [Abstract][Full Text] [Related]
15. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
16. [Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost].
Zeitz O; Matthiessen ET; Wiermann A; Reuss J; Richard G; Klemm M
Klin Monbl Augenheilkd; 2004 Jul; 221(7):550-4. PubMed ID: 15273908
[TBL] [Abstract][Full Text] [Related]
17. Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension.
Noecker RJ; Earl ML; Mundorf T; Peace J; Williams RD
Adv Ther; 2003; 20(2):121-8. PubMed ID: 12836812
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.
Cellini M; Caramazza R; Bonsanto D; Bernabini B; Campos EC
Ophthalmologica; 2004; 218(5):312-7. PubMed ID: 15334011
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Noecker R
Br J Ophthalmol; 2006 Nov; 90(11):1336-7. PubMed ID: 17057169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
